APO Research
Talk to an analyst

APO RESEARCH · REPORT

Posterior Pituitary Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Posterior Pituitary Injection Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchPosterior Pituitary Injection Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Posterior Pituitary Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Posterior Pituitary Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Posterior Pituitary Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Posterior Pituitary Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Posterior Pituitary Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Posterior Pituitary Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Posterior Pituitary Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Posterior Pituitary Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Posterior Pituitary Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Posterior Pituitary Injection market include Eisai (Liaoning) Pharmaceutical, Shanghai No. 1 Biochemical & Pharmaceutical, Shanghai Harvest Pharmaceutical, Nanjing Xinbai Pharmaceutical, Kamp Pharmaceutical, Chengdu Hepatunn Pharmaceutical, Beijing Science Sun and Anhui Hongye Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Posterior Pituitary Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Posterior Pituitary Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Posterior Pituitary Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Posterior Pituitary Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Posterior Pituitary Injection Segment by Company

Eisai (Liaoning) Pharmaceutical

Shanghai No. 1 Biochemical & Pharmaceutical

Shanghai Harvest Pharmaceutical

Nanjing Xinbai Pharmaceutical

Kamp Pharmaceutical

Chengdu Hepatunn Pharmaceutical

Beijing Science Sun

Anhui Hongye Pharmaceutical

Posterior Pituitary Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Posterior Pituitary Injection Segment by Application

Obstetric Oxytocia

Lung or Bronchi Bleeding

Gastrointestinal Bleeding

Others

Posterior Pituitary Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Posterior Pituitary Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Posterior Pituitary Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Posterior Pituitary Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Posterior Pituitary Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Posterior Pituitary Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Posterior Pituitary Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Posterior Pituitary Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Posterior Pituitary Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Posterior Pituitary Injection industry.

Chapter 3: Detailed analysis of Posterior Pituitary Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Posterior Pituitary Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Posterior Pituitary Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Posterior Pituitary Injection Industry Trends Table 2. Posterior Pituitary Injection Industry Drivers Table 3. Posterior Pituitary Injection Industry Opportunities and Challenges Table 4. Posterior Pituitary Injection Industry Restraints Table 5. Global Posterior Pituitary Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Posterior Pituitary Injection Revenue Share by Company (2021-2026) Table 7. Global Posterior Pituitary Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Posterior Pituitary Injection Sales Volume Share by Company (2021-2026) Table 9. Global Posterior Pituitary Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Posterior Pituitary Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Posterior Pituitary Injection Key Company Manufacturing Base & Headquarters Table 12. Global Posterior Pituitary Injection Company, Product Type & Application Table 13. Global Posterior Pituitary Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Posterior Pituitary Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intramuscular Injection Table 18. Significant Companies of Intravenous Drip Table 19. Global Posterior Pituitary Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Posterior Pituitary Injection Sales Volume by Type (2021-2026) & (k units) Table 21. Global Posterior Pituitary Injection Sales Volume by Type (2027-2032) & (k units) Table 22. Global Posterior Pituitary Injection Sales Volume Share by Type (2021-2026) Table 23. Global Posterior Pituitary Injection Sales Volume Share by Type (2027-2032) Table 24. Global Posterior Pituitary Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Posterior Pituitary Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Posterior Pituitary Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Posterior Pituitary Injection Sales Value Share by Type (2021-2026) Table 28. Global Posterior Pituitary Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Obstetric Oxytocia Table 30. Significant Companies of Lung or Bronchi Bleeding Table 31. Significant Companies of Gastrointestinal Bleeding Table 32. Significant Companies of Others Table 33. Global Posterior Pituitary Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Posterior Pituitary Injection Sales Volume by Application (2021-2026) & (k units) Table 35. Global Posterior Pituitary Injection Sales Volume by Application (2027-2032) & (k units) Table 36. Global Posterior Pituitary Injection Sales Volume Share by Application (2021-2026) Table 37. Global Posterior Pituitary Injection Sales Volume Share by Application (2027-2032) Table 38. Global Posterior Pituitary Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Posterior Pituitary Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Posterior Pituitary Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Posterior Pituitary Injection Sales Value Share by Application (2021-2026) Table 42. Global Posterior Pituitary Injection Sales Value Share by Application (2027-2032) Table 43. Global Posterior Pituitary Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Posterior Pituitary Injection Sales by Region (2021-2026) & (k units) Table 45. Global Posterior Pituitary Injection Sales Market Share by Region (2021-2026) Table 46. Global Posterior Pituitary Injection Sales by Region (2027-2032) & (k units) Table 47. Global Posterior Pituitary Injection Sales Market Share by Region (2027-2032) Table 48. Global Posterior Pituitary Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Posterior Pituitary Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Posterior Pituitary Injection Sales Value Share by Region (2021-2026) Table 51. Global Posterior Pituitary Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Posterior Pituitary Injection Sales Value Share by Region (2027-2032) Table 53. Global Posterior Pituitary Injection Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Posterior Pituitary Injection Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Posterior Pituitary Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Posterior Pituitary Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Posterior Pituitary Injection Sales by Country (2021-2026) & (k units) Table 58. Global Posterior Pituitary Injection Sales Market Share by Country (2021-2026) Table 59. Global Posterior Pituitary Injection Sales by Country (2027-2032) & (k units) Table 60. Global Posterior Pituitary Injection Sales Market Share by Country (2027-2032) Table 61. Global Posterior Pituitary Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Posterior Pituitary Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Posterior Pituitary Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Posterior Pituitary Injection Sales Value Market Share by Country (2027-2032) Table 65. Eisai (Liaoning) Pharmaceutical Company Information Table 66. Eisai (Liaoning) Pharmaceutical Business Overview Table 67. Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 69. Eisai (Liaoning) Pharmaceutical Recent Development Table 70. Shanghai No. 1 Biochemical & Pharmaceutical Company Information Table 71. Shanghai No. 1 Biochemical & Pharmaceutical Business Overview Table 72. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 74. Shanghai No. 1 Biochemical & Pharmaceutical Recent Development Table 75. Shanghai Harvest Pharmaceutical Company Information Table 76. Shanghai Harvest Pharmaceutical Business Overview Table 77. Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 79. Shanghai Harvest Pharmaceutical Recent Development Table 80. Nanjing Xinbai Pharmaceutical Company Information Table 81. Nanjing Xinbai Pharmaceutical Business Overview Table 82. Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 84. Nanjing Xinbai Pharmaceutical Recent Development Table 85. Kamp Pharmaceutical Company Information Table 86. Kamp Pharmaceutical Business Overview Table 87. Kamp Pharmaceutical Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Kamp Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 89. Kamp Pharmaceutical Recent Development Table 90. Chengdu Hepatunn Pharmaceutical Company Information Table 91. Chengdu Hepatunn Pharmaceutical Business Overview Table 92. Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 94. Chengdu Hepatunn Pharmaceutical Recent Development Table 95. Beijing Science Sun Company Information Table 96. Beijing Science Sun Business Overview Table 97. Beijing Science Sun Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Beijing Science Sun Posterior Pituitary Injection Product Portfolio Table 99. Beijing Science Sun Recent Development Table 100. Anhui Hongye Pharmaceutical Company Information Table 101. Anhui Hongye Pharmaceutical Business Overview Table 102. Anhui Hongye Pharmaceutical Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Anhui Hongye Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 104. Anhui Hongye Pharmaceutical Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Posterior Pituitary Injection Distributors List Table 108. Posterior Pituitary Injection Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Posterior Pituitary Injection Product Image Figure 2. Global Posterior Pituitary Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Posterior Pituitary Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Posterior Pituitary Injection Sales (2021-2032) & (k units) Figure 5. Global Posterior Pituitary Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Posterior Pituitary Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intramuscular Injection Image Figure 10. Intravenous Drip Image Figure 11. Global Posterior Pituitary Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Posterior Pituitary Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Posterior Pituitary Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Posterior Pituitary Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Posterior Pituitary Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Posterior Pituitary Injection Sales Value Share by Type (2021-2032) Figure 17. Obstetric Oxytocia Image Figure 18. Lung or Bronchi Bleeding Image Figure 19. Gastrointestinal Bleeding Image Figure 20. Others Image Figure 21. Global Posterior Pituitary Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Posterior Pituitary Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Posterior Pituitary Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Posterior Pituitary Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Posterior Pituitary Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Posterior Pituitary Injection Sales Value Share by Application (2021-2032) Figure 27. Global Posterior Pituitary Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Posterior Pituitary Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Posterior Pituitary Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Posterior Pituitary Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Posterior Pituitary Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Posterior Pituitary Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Posterior Pituitary Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Posterior Pituitary Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Posterior Pituitary Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Posterior Pituitary Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Posterior Pituitary Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Posterior Pituitary Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Posterior Pituitary Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Posterior Pituitary Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Posterior Pituitary Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Posterior Pituitary Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Posterior Pituitary Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Obstetric Oxytocia
  • Lung or Bronchi Bleeding
  • Gastrointestinal Bleeding
  • Others
Companies covered
  • Eisai (Liaoning) Pharmaceutical
  • Shanghai No. 1 Biochemical & Pharmaceutical
  • Shanghai Harvest Pharmaceutical
  • Nanjing Xinbai Pharmaceutical
  • Kamp Pharmaceutical
  • Chengdu Hepatunn Pharmaceutical
  • Beijing Science Sun
  • Anhui Hongye Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Posterior Pituitary Injection Sales Value (2021-2032)
  4. 1.2.2 Global Posterior Pituitary Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Posterior Pituitary Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Posterior Pituitary Injection Market Dynamics
  1. 2.1 Posterior Pituitary Injection Industry Trends
  2. 2.2 Posterior Pituitary Injection Industry Drivers
  3. 2.3 Posterior Pituitary Injection Industry Opportunities and Challenges
  4. 2.4 Posterior Pituitary Injection Industry Restraints
3 Posterior Pituitary Injection Market by Company
  1. 3.1 Global Posterior Pituitary Injection Company Revenue Ranking in 2025
  2. 3.2 Global Posterior Pituitary Injection Revenue by Company (2021-2026)
  3. 3.3 Global Posterior Pituitary Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Posterior Pituitary Injection Average Price by Company (2021-2026)
  5. 3.5 Global Posterior Pituitary Injection Company Ranking (2024-2026)
  6. 3.6 Global Posterior Pituitary Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Posterior Pituitary Injection Company Product Type and Application
  8. 3.8 Global Posterior Pituitary Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Posterior Pituitary Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Posterior Pituitary Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Posterior Pituitary Injection Market by Type
  1. 4.1 Posterior Pituitary Injection Type Introduction
  2. 4.1.1 Intramuscular Injection
  3. 4.1.2 Intravenous Drip
  4. 4.2 Global Posterior Pituitary Injection Sales Volume by Type
  5. 4.2.1 Global Posterior Pituitary Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Posterior Pituitary Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Posterior Pituitary Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Posterior Pituitary Injection Sales Value by Type
  9. 4.3.1 Global Posterior Pituitary Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Posterior Pituitary Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Posterior Pituitary Injection Sales Value Share by Type (2021-2032)
5 Posterior Pituitary Injection Market by Application
  1. 5.1 Posterior Pituitary Injection Application Introduction
  2. 5.1.1 Obstetric Oxytocia
  3. 5.1.2 Lung or Bronchi Bleeding
  4. 5.1.3 Gastrointestinal Bleeding
  5. 5.1.4 Others
  6. 5.2 Global Posterior Pituitary Injection Sales Volume by Application
  7. 5.2.1 Global Posterior Pituitary Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Posterior Pituitary Injection Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Posterior Pituitary Injection Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Posterior Pituitary Injection Sales Value by Application
  11. 5.3.1 Global Posterior Pituitary Injection Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Posterior Pituitary Injection Sales Value by Application (2021-2032)
  13. 5.3.3 Global Posterior Pituitary Injection Sales Value Share by Application (2021-2032)
6 Posterior Pituitary Injection Regional Sales and Value Analysis
  1. 6.1 Global Posterior Pituitary Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Posterior Pituitary Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Posterior Pituitary Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Posterior Pituitary Injection Sales by Region (2027-2032)
  5. 6.3 Global Posterior Pituitary Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Posterior Pituitary Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Posterior Pituitary Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Posterior Pituitary Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Posterior Pituitary Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Posterior Pituitary Injection Sales Value (2021-2032)
  12. 6.6.2 North America Posterior Pituitary Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Posterior Pituitary Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Posterior Pituitary Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Posterior Pituitary Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Posterior Pituitary Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Posterior Pituitary Injection Sales Value (2021-2032)
  21. 6.9.2 South America Posterior Pituitary Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Posterior Pituitary Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Posterior Pituitary Injection Sales Value Share by Country, 2025 VS 2032
7 Posterior Pituitary Injection Country-level Sales and Value Analysis
  1. 7.1 Global Posterior Pituitary Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Posterior Pituitary Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Posterior Pituitary Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Posterior Pituitary Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Posterior Pituitary Injection Sales by Country (2027-2032)
  6. 7.4 Global Posterior Pituitary Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Posterior Pituitary Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Posterior Pituitary Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Posterior Pituitary Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Posterior Pituitary Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Posterior Pituitary Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai (Liaoning) Pharmaceutical
  2. 8.1.1 Eisai (Liaoning) Pharmaceutical Company Information
  3. 8.1.2 Eisai (Liaoning) Pharmaceutical Business Overview
  4. 8.1.3 Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Product Portfolio
  6. 8.1.5 Eisai (Liaoning) Pharmaceutical Recent Developments
  7. 8.2 Shanghai No. 1 Biochemical & Pharmaceutical
  8. 8.2.1 Shanghai No. 1 Biochemical & Pharmaceutical Company Information
  9. 8.2.2 Shanghai No. 1 Biochemical & Pharmaceutical Business Overview
  10. 8.2.3 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Product Portfolio
  12. 8.2.5 Shanghai No. 1 Biochemical & Pharmaceutical Recent Developments
  13. 8.3 Shanghai Harvest Pharmaceutical
  14. 8.3.1 Shanghai Harvest Pharmaceutical Company Information
  15. 8.3.2 Shanghai Harvest Pharmaceutical Business Overview
  16. 8.3.3 Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Product Portfolio
  18. 8.3.5 Shanghai Harvest Pharmaceutical Recent Developments
  19. 8.4 Nanjing Xinbai Pharmaceutical
  20. 8.4.1 Nanjing Xinbai Pharmaceutical Company Information
  21. 8.4.2 Nanjing Xinbai Pharmaceutical Business Overview
  22. 8.4.3 Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Product Portfolio
  24. 8.4.5 Nanjing Xinbai Pharmaceutical Recent Developments
  25. 8.5 Kamp Pharmaceutical
  26. 8.5.1 Kamp Pharmaceutical Company Information
  27. 8.5.2 Kamp Pharmaceutical Business Overview
  28. 8.5.3 Kamp Pharmaceutical Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kamp Pharmaceutical Posterior Pituitary Injection Product Portfolio
  30. 8.5.5 Kamp Pharmaceutical Recent Developments
  31. 8.6 Chengdu Hepatunn Pharmaceutical
  32. 8.6.1 Chengdu Hepatunn Pharmaceutical Company Information
  33. 8.6.2 Chengdu Hepatunn Pharmaceutical Business Overview
  34. 8.6.3 Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Product Portfolio
  36. 8.6.5 Chengdu Hepatunn Pharmaceutical Recent Developments
  37. 8.7 Beijing Science Sun
  38. 8.7.1 Beijing Science Sun Company Information
  39. 8.7.2 Beijing Science Sun Business Overview
  40. 8.7.3 Beijing Science Sun Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Science Sun Posterior Pituitary Injection Product Portfolio
  42. 8.7.5 Beijing Science Sun Recent Developments
  43. 8.8 Anhui Hongye Pharmaceutical
  44. 8.8.1 Anhui Hongye Pharmaceutical Company Information
  45. 8.8.2 Anhui Hongye Pharmaceutical Business Overview
  46. 8.8.3 Anhui Hongye Pharmaceutical Posterior Pituitary Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Anhui Hongye Pharmaceutical Posterior Pituitary Injection Product Portfolio
  48. 8.8.5 Anhui Hongye Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Posterior Pituitary Injection Value Chain Analysis
  2. 9.1.1 Posterior Pituitary Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Posterior Pituitary Injection Sales Mode & Process
  6. 9.2 Posterior Pituitary Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Posterior Pituitary Injection Distributors
  9. 9.2.3 Posterior Pituitary Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst